Studies from Tokyo Medical University Have Provided New Data on Health Insurance (Cost-Benefit Performance Simulation of Robot-Assisted Thoracic…

Managed Care Weekly Digest

Studies from Tokyo Medical University Have Provided New Data on Health Insurance (Cost-Benefit Performance Simulation of Robot-Assisted Thoracic Surgery As Required for Financiall Viability under the 2016 Revised Reimbursement Paradigm of the ...)

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- Current study results on Health Insurance have been published. According to news reporting from Tokyo, Japan, by NewsRx journalists, research stated, "To discuss the cost-benefit performance (CBP) and establish a medical fee system for robotic-assisted thoracic surgery (RATS) under the Japanese National Health Insurance System (JNHIS), which is a system not yet firmly established. All management steps for RATS are identical, such as preoperative and postoperative management."

The news correspondents obtained a quote from the research from Tokyo Medical University, "This study examines the CBP based on medical fees of RATS under the JNHIS introduced in 2016. Robotic-assisted laparoscopic prostatectomy (RALP) and robotic-assisted partial nephrectomy (RAPN) now receive insurance reimbursement under the category of use of support devices for endoscopic surgery ($5420 and $3485, respectively). If the same standard amount were to be applied to RATS, institutions would need to perform at least 150 or 300 procedures thoracic operation per year to show a positive CBP ($317 per procedure as same of RALP and $130 per procedure as same of RAPN, respectively). Robotic surgery in some areas receives insurance reimbursement for its 'supportive' use for endoscopic surgery as for RALP and RAPN."

According to the news reporters, the research concluded: "However, at present, it is necessary to perform da Vinci Surgical System Si (dVSi) surgery at least 150-300 times in a year in a given institution to prevent a deficit in income."

For more information on this research see: Cost-Benefit Performance Simulation of Robot-Assisted Thoracic Surgery As Required for Financiall Viability under the 2016 Revised Reimbursement Paradigm of the Japanese National Health Insurance System. Annals of Thoracic and Cardiovascular Surgery, 2018;(): (see also Health Insurance).

Our news journalists report that additional information may be obtained by contacting N. Kajiwara, Dept. of Surgery, Tokyo Medical University, Tokyo, Japan. Additional authors for this research include Y. Kato, M. Hagiwara, M. Kakihana, T. Ohira, N. Kawate and N. Ikeda.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.5761/atcs.oa.17-00094. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Tokyo, Japan, Surgery, Robotics, Medical Fees, Health Insurance, Machine Learning, Medical Economics, Health and Medicine, Insurance Companies, Emerging Technologies, Investment and Finance.